Bardzo tanie apteki z dostawą w całej Polsce kupic levitra i ogromny wybór pigułek.

Cfppdl-6-0106.qxp

January 2006
Updated 01/01/2006
For the most up-to-date Primary/Preferred Drug List visit www.caremark.com
NUCLEOSIDE
LUTEINIZING
ANTILIPEMICS
NITRATES
REVERSE-
HORMONE-
§ BILE ACID RESIN
SUBLINGUAL
ANTIBACTERIALS
TRANSCRIPTASE
ALKYLATING AGENTS
RELEASING HORMONE
§ CEPHALOSPORIN
INHIBITOR
(LHRH) AGONISTS
CHOLESTEROL
§ TRANSDERMAL
COMBINATIONS
ABSORPTION
§ ERYTHROMYCINS/
INHIBITOR
MACROLIDES
CENTRAL NERVOUS
§ FIBRATE
SYSTEM§
§ FLUOROQUINOLONES
NUCLEOTIDE
ANTIMETABOLITES
§ ANTICONVULSANTS
§ HMG-CoA
§ ACE INHIBITOR
REVERSE-
REDUCTASE
TRANSCRIPTASE
INHIBITORS
INHIBITOR
ACE INHIBITOR/
MISCELLANEOUS
CALCIUM CHANNEL
KETOLIDE
PROTEASE INHIBITORS
BLOCKERS
§ ANTIFUNGAL
§ ADRENOLYTIC,
§ BETA-BLOCKERS
ANTIRETROVIRALS
FUSION INHIBITOR
TYROSINE KINASE
INHIBITORS
ANGIOTENSIN II
§ CALCIUM CHANNEL
NON-NUCLEOSIDE
RECEPTOR
ANTIDEMENTIA
REVERSE-
ANTAGONISTS
TRANSCRIPTASE
ANTIVIRALS
ATACAND#
INHIBITORS
HORMONAL
CALCIUM CHANNEL
§ CYTOMEGALOVIRUS
ANTINEOPLASTIC
BLOCKER/ANTILIPEMIC
COMBINATION
ANTIANDROGEN
§ HEPATITIS AGENTS
ANGIOTENSIN II
§ NUCLEOSIDE
RECEPTOR
ANTIDEPRESSANTS
ANTIESTROGENS
§ DIGITALIS GLYCOSIDE
REVERSE-
ANTAGONIST
§ MISCELLANEOUS
TRANSCRIPTASE
COMBINATIONS
INHIBITORS
ATACAND HCT#
ENDOTHELIN RECEPTOR
AROMATASE
MONOAMINE OXIDASE
INHIBITORS
ANTAGONIST
§ HERPES AGENT
INHIBITORS (MAOIs)
§ ANTIARRHYTHMICS
§ INFLUENZA AGENT
FOR YOUR INFORMATION: Generics should be considered the first line of prescribing. The Caremark Primary/Preferred Drug List is not inclusive nor does it
guarantee coverage, but represents a summary of prescription coverage. The plan participant's specific prescription benefit plan may have a different co-pay*
for specific products on the list. Unless specifically indicated, drug list products will include all dosage forms. To check coverage and co-payments for a specific
medicine, log in to www.caremark.com.
Atacand should be reserved for participants who meet CHARM (Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity) trialcriteria.
* Co-payment or co-pay means the amount a plan participant is required to pay for a prescription in accordance with a Plan, which may be a deductible,
a percentage of the prescription price, a fixed amount or other charge, with the balance, if any, paid by a Plan.
§ Generics are available in this class and should be considered as the first line of prescribing.
§ SELECTIVE
§ MUSCULOSKELETAL
EXTENDED CYCLE
RAPAMYCIN
SEROTONIN
THERAPY AGENT
DERIVATIVE
REUPTAKE INHIBITORS
TRANSDERMAL
§ ANTIEMETIC
§ BENIGN PROSTATIC
HYPERPLASIA
ENDOCRINE AND
METABOLIC
FOLIC ACID
ANDROGENS
COMBINATION
SEROTONIN
ESTROGENS
ANTIOBESITY – FAT
ERECTILE
NOREPINEPHRINE
ABSORPTION
DYSFUNCTION
REUPTAKE INHIBITORS
DECREASING AGENT
PHOSPHODIESTERASE
§ PRENATAL VITAMIN
(SNRIs)†
INHIBITORS
ANTIDIABETICS
§ TRANSDERMAL,
ALPHA-GLUCOSIDASE
§ ANTISPASMODIC
ESTROGENS
INHIBITOR
ALPROSTADIL AGENT
ANAPHYLAXIS
INSULINS
§ CHOLELITHOLYTIC
§ ANTIPARKINSONIAN
TREATMENT AGENTS
§ URINARY
ORAL ESTROGEN/
INFLAMMATORY
ANTISPASMODICS
PROGESTIN
BOWEL DISEASE
§ ANTICHOLINERGICS
§ ORAL AGENTS
ANTIPSYCHOTICS
INSULIN SENSITIZERS
§ RECTAL AGENTS
ANTICHOLINERGIC/
INSULIN SENSITIZER/
BETA AGONIST
BIGUANIDE
FERTILITY REGULATORS
§ ANTICOAGULANT
COMBINATION
§ LAXATIVE
§ ATTENTION DEFICIT
HYPERACTIVITY
MEGLITINIDE
PLATELET
DISORDER/
ANTIHISTAMINE, LOW
PANCREATIC ENZYMES
AGGREGATION
NARCOLEPSY
SEDATING
§ SULFONYLUREA
INHIBITORS
ZYRTEC**
SUPPLIES
HUMAN GROWTH
§ ANTIHISTAMINE,
HORMONES
NONSEDATING
AND KITS
ALLEGRA**
§ PROTON PUMP
INHIBITORS
IMMUNOMODULATORS
§ ANTIHISTAMINE/
INTERFERONS
DECONGESTANTS
HYPNOTIC, NON-
ALLEGRA-D**
BENZODIAZEPINE
ZYRTEC-D 12 HOUR**
PROTON PUMP
BISPHOSPHONATES
INHIBITOR WITH
§ PROGESTIN
INTERFERON/ANTIVIRAL
§ BETA AGONISTS
MIGRAINE
ANTI-INFECTIVE
COMBINATION
SELECTIVE SEROTONIN
AGONISTS
SELECTIVE ESTROGEN
§ RECTAL STEROID
CONTRACEPTIVES
RECEPTOR
IMMUNOSUPPRESSANTS
MODULATOR
§ MONOPHASIC
ANTIMETABOLITES
§ DECONGESTANT/
SALIVA STIMULANT
§ BIPHASIC
EXPECTORANT
MULTIPLE SCLEROSIS
§ THYROID
§ CALCINEURIN
SUPPLEMENT
§ TRIPHASIC
INHIBITORS
LEUKOTRIENE
RECEPTOR
ANTAGONIST
Indicates the proposed mechanism of action, based on the American Psychiatric Association Summary of Treatment Recommendations.
An Accu-Chek or OneTouch blood glucose meter will be provided at no charge by the manufacturer to those individuals currently using a meter other thanAccu-Chek or OneTouch. For more information on how to obtain a blood glucose meter, call toll-free: 1-800-588-4456.
** Higher co-payments may apply depending on the plan participant’s specific prescription benefit plan. To find the co-payment under a specific plan, log in to
www.caremark.com.
§ Generics are available in this class and should be considered as the first line of prescribing.
NASAL ANTIHISTAMINE
§ LOCAL ANALGESIC
§ ANTI-INFECTIVE/
CARBONIC
ANTI-INFLAMMATORY
ANHYDRASE
DERMATOLOGY
§ ROSACEA
INHIBITOR/
§ NASAL STEROIDS
§ ANTI-INFLAMMATORY,
BETA-BLOCKER
STEROIDAL
§ STEROIDS
IMMUNOMODULATOR
1-800-282-2229.
§ ANTI-INFLAMMATORY,
NONSTEROIDAL
PROSTAGLANDINS
§ ACTINIC KERATOSIS
STEROID/BETA
§ ANTIBIOTICS
§ BETA-BLOCKER,
§ SYMPATHOMIMETIC
NONSELECTIVE
MISCELLANEOUS SKIN
AND MUCOUS
STEROID INHALANTS
§ ANTIFUNGALS
MEMBRANE
BETA-BLOCKER,
SELECTIVE
ANTI-INFECTIVE
ANTIPSORIATIC
§ ANTI-INFECTIVE/
§ XANTHINE
CARBONIC
ANTI-INFLAMMATORY
OPHTHALMIC
ANHYDRASE
§ ANTIALLERGICS
INHIBITORS
IMMUNOMODULATORS
§ Generics are available in this class and should be considered as the first line of prescribing.
** Higher co-payments may apply depending on the plan participant’s specific prescription benefit plan. To find the co-payment under a specific plan, log in to
www.caremark.com.
Caremark may receive rebates, discounts and service fees from pharmaceutical manufacturers for certain listed products.
The Caremark Primary/Preferred Drug List contains prescription brand name medicines that are registered or trademarks of pharmaceutical manufacturers that arenot affiliated with Caremark Inc. Listed products are for informational purposes only and are not intended to replace the clinical judgment of the prescriber.
QUICK REFERENCE BRAND PRIMARY/PREFERRED DRUG LIST
ATACAND#
ATACAND HCT#
ALLEGRA**
ALLEGRA-D**
Atacand should be reserved for participants who meet CHARM (Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity) trialcriteria.
** Higher co-payments may apply depending on the plan participant’s specific prescription benefit plan. To find the co-payment under a specific plan, log in to
www.caremark.com.
ZYRTEC**
ZYRTEC-D 12 HOUR**
** Higher co-payments may apply depending on the plan participant’s specific prescription benefit plan. To find the co-payment under a specific plan, log in to
www.caremark.com.
The Caremark Primary/Preferred Drug List contains prescription brand name medicines that are registered or trademarks of pharmaceutical manufacturers that arenot affiliated with Caremark Inc. Listed products are for informational purposes only and are not intended to replace the clinical judgment of the prescriber.
2006 Caremark Inc. All rights reserved. www.caremark.com

Source: http://www.ha-prod.com/newswriter/attachments/caremark_drug_list.pdf

Aanspreekpartners van de csg:

Contacts: Advice for Friends and Acquaintances of Cluster Headache Sufferers. Please request a disc from the adress or download the required information from the below homepage Changes to the text or layout is prohibited Manfred Sander, 37603 Holzminden Tel. 05531-140007 Clusterheadache Patient´s group Tel. 02562-965255 [email protected]

Microsoft word - asc 2011 formulary v 1.doc

Fluconazole* (Diflucan) GENERIC DRUGS Itraconazole* (Sporanox) Ascension Health endorses the use of FDA Ketoconazole* (Nizoral) Nystatin* (Mycostatin) encourages the prescribing and dispensing of Terbinafine* (Lamisil) (QL) these generic medications whenever medically ANTI-MALARIALS ____________________________ Chloroquine* (Aralen) EXCLUDED DRUGS Hydroxy

Copyright © 2010-2014 Medical Articles